Menu

 

Feature

Commentary: The risk of over-regulation

BMJ 2011; 342 doi: http://dx.doi.org/10.1136/bmj.d3021 (Published 15 May 2011)
Cite this as: BMJ 2011;342:d3021

Related articles

Editor's Choice: The trouble with medical devices

Published 18 May 2011; BMJ 342 doi: 10.1136/bmj.d3123

Feature: Commentary: Metal on metal hips

Published 15 May 2011; BMJ 342 doi: 10.1136/bmj.d3009

Feature: Out of joint: The story of the ASR

Published 15 May 2011; BMJ 342 doi: 10.1136/bmj.d2905

Feature: Commentary: International collaboration needed on device clinical standards

Published 15 May 2011; BMJ 342 doi: 10.1136/bmj.d2952

Feature: Commentary: Use of registries to investigate the past and develop the future

Published 15 May 2011; BMJ 342 doi: 10.1136/bmj.d2826

Feature: Commentary: Evaluating and regulating device therapy

Published 15 May 2011; BMJ 342 doi: 10.1136/bmj.d2839

Feature: Europeans are left to their own devices

Published 15 May 2011; BMJ 342 doi: 10.1136/bmj.d2748

Editorial: The regulation of medical devices

Published 14 May 2011; BMJ 342 doi: 10.1136/bmj.d2822

See more

Research: Risk of incident diabetes among patients treated with statins: population based study

Published 23 May 2013; BMJ 346 doi: 10.1136/bmj.f2610

Editorial: Statins and the risk of developing diabetes

Published 23 May 2013; BMJ 346 doi: 10.1136/bmj.f3156

Letter: BMJ shortlisted trial of Edwards-SAPIEN valve does not include all randomised patients

Published 22 May 2013; BMJ 346 doi: 10.1136/bmj.f3229

This article has been cited by other articles:

Latest comments and most commented

THIS WEEK'S POLL

Read related article

See previous polls